Parenteral nutrition effect on serum insulin in the preterm infant

S Andronikou1, I Hanning

  • 1Neonatal Care Nursery, University of Newcastle Upon Tyne, Princess Mary Maternity Hospital, England.

Pediatrics
|November 1, 1987
PubMed

Insights

Adding amino acids to glucose infusions for preterm infants did not cause hypoglycemia. Preterm infants receiving both amino acids and glucose showed higher insulin levels but stable blood glucose.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology
  • Nutritional Support

Background:

  • Preterm infants often require parenteral nutrition due to feeding difficulties.
  • Respiratory distress syndrome is common in preterm infants, necessitating mechanical ventilation.
  • Understanding the metabolic response to parenteral nutrition is crucial for stable preterm infants.

Purpose of the Study:

  • To investigate the effect of amino acid supplementation on blood glucose and serum insulin levels in preterm infants.
  • To determine if combined amino acid and glucose infusion impacts glycemic control.
  • To assess the safety of amino acid-containing parenteral nutrition in mechanically ventilated preterm infants.

Main Methods:

  • Two matched groups of preterm infants receiving mechanical ventilation were studied.
  • Group A received 10% glucose infusion; Group B received 10% glucose plus amino acid solution.
  • Blood glucose and serum insulin levels were measured at 24 and 48 hours.

Main Results:

  • No significant differences in blood glucose or insulin levels were observed at 24 hours.
  • At 48 hours, infants receiving amino acids and glucose had significantly higher insulin levels (P < .01).
  • Blood glucose levels remained stable in both groups throughout the study period.

Conclusions:

  • Continuous amino acid infusion in stable preterm infants does not lead to hypoglycemia, despite increased insulin levels.
  • Parenteral nutrition with both glucose and amino acids is metabolically safe regarding glycemic control in this population.
  • This finding supports the use of combined amino acid and glucose parenteral nutrition for preterm infants.

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...